Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases

Fong Y, Kemeny N, Paty P, et al. Treatment of colorectal cancer hepatic metastasis. Semin Surg Oncol 1996; 12: 219?52.

Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer: biologic perspectives. Ann Surg 1989; 210: 127?38.

Weiss L, Grundmann E, Torhorst J, et al. Hematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986; 150: 195?203.

Fortner JG, Silva JS, Golbey RB, et al. Multi-variate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg 1984; 199: 306?16.

Adson MA, Van Heerden JA, Adson MH, et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 1984; 119: 647?51.

Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Surgery 1988; 103: 278?88.

Nordlinger B, Jaeck D, Guiguet M, et al. Traitement des metastases hepatiques des cancers colorectaux. Monographies de l? Association Francaise de Chirurgie (AFC). 1992; 129?46. Paris, France: Springer Verlag,

Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg 1995; 19: 59?71.

Fong Y, Cohen A, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15: 938?46.

Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509?22.

Adson MA, Resectionof liver metastases. When is it worthwhile? World J Surg 1987; 11: 511?20.

Doci R, Gennari L, Bignami P, et al. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991; 78: 797?801.

Levi F, Misset JL, Brienza S, et al. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid and oxaliplatin using an ambulatory multichannel programmable pump. Cancer 1992; 69: 893?900.

Azoulay D, Raccuia JS, Castaing D, et al. Right portal vein embolization in preparation for major hepatic resection. J Am Coll Surg 1995; 181: 267?9.

Fowler WC, Eisenberg BL, Hoffman JP. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol 1992; 51: 122?5.

Elias D, Lasser P, Rougier P, et al. Frequency, technical aspects, results and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 1995; 180: 213?9.

Giachetti S, Itzhaki M, Gruia G, et al. Long term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999; 10: 663?9.

Becouarn Y, Ychou M, Ducreux M, et al. Oxaliplatin (L-OHP) as first line chemotherapy in metastatic colorectal cancer (MRC) patients: preliminary activity/toxicity report [Abstract]. Proc Am Soc Clin Oncol 1997; 16: 229A.

Levi F, Giacchetti S, Adam R, et al. Chronomodulation of chemotherapy against metastatic colorectal cancer. Eur J Cancer 1995; 31A: 1264?70.

Levi F, Zidani R, Brienza S, et al. A multicenter evaluation of intensified ambulatory chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. Cancer 1999; 85: 2532?40.

Bertheault-Cvitkovic F, Jami.A, Ithzaki M, et al. Bi weekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with metastatic colorectal cancer. J Clin Oncol 1996; 14: 2950?8.

Levi F, Zidani R, Vannetzel JM, et al. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst 1994; 86: 1608?17.

Levi F, Zidani R, Misset JL, et al. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 1997; 350: 681?6.

Murata S, Moriya Y, Akasu T, et al. Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 1998; 83: 1086?93.

Regnard JF, Grunenwald D, Spaggiari L, et al. Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 1998; 66: 214?9.